Category Archives: Press Releases

Abacus Health Products Adds New Distribution Partner and Announces Expansion of Retail Presence with Existing and New Retail Chains   

Abacus Health Products Adds New Distribution Partner and Announces Expansion of Retail Presence with Existing and New Retail Chains Woonsocket, RI – August 15, 2019 – Abacus Health Products, Inc. (CSE: ABCS) (OTCQX: ABAHF) (“Abacus” or the “Company”) today announced the addition of Matrix Distributors, Inc. (“Matrix Distributors”) as a distributor of its CBDMEDIC™ products. The […]

Abacus Health Products Announces Release Date, Conference Call and Webcast Details for 2019 Second Quarter Financial Results

Abacus Health Products Announces Release Date, Conference Call and Webcast Details for 2019 Second Quarter Financial Results Woonsocket, RI – August 13, 2019 – Abacus Health Products, Inc. (CSE: ABCS, OTCQX: ABAHF) (“Abacus” or the “Company”) will release its 2019 second quarter financial results on Thursday, August 29, 2019, after market close. Management will host a conference […]

Abacus Health Products Announces Addition to Board of Directors 

Abacus Health Products Announces Addition to Board of Directors Woonsocket, RI and Toronto, ON – July 31, 2019 – Abacus Health Products, Inc. (“Abacus” or the “Company”) (CSE: ABCS) (OTCQX: ABAHF) is pleased to announce that Mr. Hannan Fleiman has joined its board of directors.  Mr. Fleiman will also serve as Chair of the Company’s Audit […]

Abacus Health Products Announces New Retail Purchase Order for CBDMEDIC™ Products

Abacus Health Products Announces New Retail Purchase Order for CBDMEDIC™ Products     Woonsocket, RI – July 17, 2019 – Abacus Health Products, Inc. (CSE: ABCS) (OTCQX: ABAHF) (“Abacus” or the “Company”) today announced a new retail purchase order by Valu Merchandisers Company for its line of CBDMEDIC™ products. Valu Merchandisers – a cooperative food distributor serving […]

Abacus Health Products Announces New Retail Purchase Orders and Provides CBDMEDIC™ Update

Abacus Health Products Announces New Retail Purchase Orders and Provides CBDMEDIC™ Update Woonsocket, RI – July 11, 2019 – Abacus Health Products (“Abacus” or the “Company”) (CSE: ABCS) today announced new retail purchase orders for its line of CBDMEDIC™ products, which are sold to consumers via retail chains and the company’s e-commerce platform. Abacus is […]

Abacus Health Products Begins Trading on the OTC Market

  Abacus Health Products Begins Trading on the OTC Market                                               Woonsocket, RI – July 2, 2019 – Abacus Health Products, Inc. (“Abacus” or the “Company”) (CSE: ABCS) (OTCQX: ABAHF) today announced its subordinate voting shares have begun trading on the OTCQX Market under the symbol “ABAHF” effective July 1, 2019. “Having a dual listing on […]

Abacus CEO Perry Antelman to Speak at the Inaugural Institutional Capital & Cannabis Conference Europe

  Abacus CEO Perry Antelman to Speak at the Inaugural Institutional Capital & Cannabis Conference Europe Woonsocket, RI – June 13, 2019 – Abacus Health Products (“Abacus” or the “Company”) (CSE: ABCS) CEO Perry Antelman will be a panel participant at the inaugural Institutional Capital & Cannabis Conference Europe (IC3 Europe) to be held in […]

Abacus Health Products Reports First Quarter 2019 Financial Results

Abacus Health Products Reports First Quarter 2019 Financial Results Toronto, ON – May 30, 2019 – Abacus Health Products, Inc. (CSE: ABCS) (“Abacus” or the “Company”) reported its financial results today for the first quarter ended March 31, 2019. All amounts are in U.S. dollars unless indicated otherwise. Q1 2019 Financial Summary Revenue increased 166% […]

Abacus Health Products Announces Release Date, Conference Call and Webcast Details for 2019 First Quarter Financial Results

Abacus Health Products, Inc. (CSE: ABCS) will release its 2019 first quarter financial results on Thursday, May 30, 2019, after market close. Management will host a conference call the following day, Friday, May 31, 2019, at 10:00 AM Eastern Time to review the financial results.

Skip to content